Prosecution Insights
Last updated: October 04, 2026

Suzhou Qi Biodesign Biotechnology Company Limited

Technology area: Biotechnology & Pharmaceuticals

4 pending office actions • 4 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready

Analysis

Suzhou Qi Biodesign Biotechnology Company Limited is currently managing 4 pending office actions within the Biotechnology & Pharmaceuticals technology area. These actions are distributed across 4 distinct examiners and 4 distinct art units, indicating a broad and diversified prosecution strategy. This distribution suggests that the company's innovations are being reviewed by multiple specialized groups within the USPTO.

The busiest examiner for the portfolio is KINGDON, CATHY, who is responsible for 1 pending office action. Given that there are 4 pending office actions in total, the workload is spread, with no single examiner handling more than 1 case. This lack of concentration requires the company to manage 4 separate examiner relationships and navigate the specific nuances of 4 different art units simultaneously.

The presence of 4 distinct art units for the 4 pending actions highlights a high degree of technical variety in the company's current filings. Practitioners must adapt their strategies to the diverse expectations of these different units. The data reflects a portfolio that is actively engaged across multiple fronts of the patent examination process under examiners like KINGDON, CATHY.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

4
Total Pending OAs
1
Non-Final OAs
3
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

2
Hard (50%)
1
Medium (25%)
1
Easy (25%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other1 (25%)
§103 only1 (25%)
§112 only1 (25%)
Multi-statute (no §101)1 (25%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

4
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

40 h
Manual time on pending OAs
8 h
Time saved (low, 20%)
14 h
Time saved (mid, 35%)
0.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
KINGDON, CATHY 1 80.3% +2.5%
CHATTERJEE, JAYANTA 1 45.5% +80.0%
PRIEST, AARON A 1 61.3% +25.7%
PARISI, JESSICA DANIELLE 1 75.8% +32.3%

Hard Cases (2)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18689009 Improved Prime Editing System KINGDON, CATHY —
17923264 DIRECTED EVOLUTION METHOD BASED ON PRIMARY AND SECONDARY REPLICON OF GEMINI VIRUS PARISI, JESSICA DANIELLE —

Interview Candidates (3)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
17909309 MULTIPLEX GENOME EDITING METHOD AND SYSTEM CHATTERJEE, JAYANTA 72d overdue
17909308 METHOD FOR DETECTING RANDOM OFF-TARGET EFFECT OF SINGLE-BASE EDITING SYSTEM PRIEST, AARON A —
17923264 DIRECTED EVOLUTION METHOD BASED ON PRIMARY AND SECONDARY REPLICON OF GEMINI VIRUS PARISI, JESSICA DANIELLE —

Top Art Units

Art UnitApps
1663 1
1662 1
1681 1
1684 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18689009 Improved Prime Editing System KINGDON, CATHY 1663 §102§103§112 Non-Final OA — Pending Mar 04, 2024
17909309 MULTIPLEX GENOME EDITING METHOD AND SYSTEM CHATTERJEE, JAYANTA 1662 §103 Final Rejection 72d overdue Pending Sep 21, 2023
17909308 METHOD FOR DETECTING RANDOM OFF-TARGET EFFECT OF SINGLE-BASE EDITING SYSTEM PRIEST, AARON A 1681 §112 Final Rejection — Pending Mar 13, 2023
17923264 DIRECTED EVOLUTION METHOD BASED ON PRIMARY AND SECONDARY REPLICON OF GEMINI VIRUS PARISI, JESSICA DANIELLE 1684 §101§102§103§112 Final Rejection — Pending Nov 04, 2022

Managing Suzhou Qi Biodesign Biotechnology Company Limited's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month